Jason Bertola, executive director of Commercial Development for the Advanced Synthesis Platform at Lonza in North America, explains the demand for spray drying and the hurdles involved with scale up, in an interview with PharmTech.
|Articles|February 19, 2014
Equipment and Processing Report
- Equipment and Processing Report-02-19-2014
- Volume 0
- Issue 0
Omega Design Corporation System Prints and Verifies Unit-Level Data on Cartons
The Intelli-Code Carton Coding and Inspection System connects to serialization data-management systems.
Omega Design Corporation’s Intelli-Code Carton Coding and Inspection System prints unit-level data on individual cartons using thermal ink-jet or laser printing and employs an integrated vision system to verify printed data. The system can be incorporated into new or existing carton lines or deployed as part of an independent serialization cell. It supports a variety of customer choices regarding preferred printing technologies, camera and inspection vision systems, and connectivity to serialization software from a variety of providers.
Source:
Articles in this issue
over 12 years ago
Complying with Revised USP Chapters on Weighingover 12 years ago
Schreiner MediPharm Introduces SecuMed Labeling Systemover 12 years ago
Developments in Producing MicrospheresRelated to this article
Ron Scarboro, Azurity Pharmaceuticals, explains when formulation robustness justifies added cost and which post-approval quality and supply metrics teams can track.
The winners of the CPHI Pharma Awards 2026 include a neurodegeneration platform, a track-and-trace packaging innovation, a enzymatic mRNA manufacturing technology, and a cell-free enzymatic biomanufacturing platform.
Richard Jaenisch explains why NAMs are compressing drug development faster than AI and what FDA's new nonclinical testing rule means for sponsors.
Hovione's $35M CDC Flex line links spray drying to tablets, designed to eliminate scale-up under FDA Q13 guidance.
This week on PharmTech, Merck diversified its pipeline, USP emphasizes supply chain security, AI systems are examined, and speakers preview their presentations at CPHI Milan and AAPS PharmSci 360.
Ron Scarboro, Azurity Pharmaceuticals, claims drug reformulation that removes patient barriers must preserve efficacy, urging early cross-functional team alignment.
Novartis licenses Abogen's mRNA-encoded T-cell engager for autoimmune disease, raising scale-up questions for mRNA-lipid nanoparticle manufacturing.
Trending on Pharmaceutical Technology
1
Winners of the 2026 CPHI Pharma Awards Announced
2
Thermo Fisher Scientific Exhibits New Solutions and Expanded Capabilities at CPHI Milan
3
CPHI Milan 2026: Nitrosamine Risk Mitigation, Part 1
4
Can Continuous Tableting End Scale-Up for Complex Oral Drugs?
5